Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

649 Articles

Chris Lange | Oct 29, 2018 at 9:45 AM EDT

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development…

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Oct 5, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 22, 2018 at 7:20 AM EDT

The Top IPOs From This Week

With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang…

Chris Lange | Sep 20, 2018 at 1:45 PM EDT

Elanco Explodes Into the Market in IPO

Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 29, 2018 at 12:15 PM EDT

Elanco Closes in on IPO

Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 3, 2018 at 10:40 AM EDT

Eli Lilly to Spin Off Elanco in IPO

Animal health company Elanco Animal Health has filed with the SEC regarding its initial public offering.

Jon C. Ogg | Jul 25, 2018 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin, Philip Morris, Rio Tinto, Spotify and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin,…

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 19 20 21 22 23 … 44

Eli Lilly : LLY

All Eli Lilly Articles

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

Short Sellers Grow More Selective on Major Pharma Stocks

The Top IPOs From This Week

Elanco Explodes Into the Market in IPO

Short Sellers Back Off Major Pharma Stocks

Elanco Closes in on IPO

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Short Sellers Hike Bets in Major Pharma Stocks

Eli Lilly to Spin Off Elanco in IPO

Top Analyst Upgrades and Downgrades: Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin, Philip Morris, Rio Tinto, Spotify and More

Major Pharma Stocks Scare Off Short Sellers

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Eli Lilly : LLY

All Eli Lilly Articles

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Major Pharma Short Sellers Hike Their Bets

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

Short Sellers Grow More Selective on Major Pharma Stocks

The Top IPOs From This Week

Elanco Explodes Into the Market in IPO

Short Sellers Back Off Major Pharma Stocks

Elanco Closes in on IPO

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Short Sellers Hike Bets in Major Pharma Stocks

Eli Lilly to Spin Off Elanco in IPO

Top Analyst Upgrades and Downgrades: Broadcom, China Life, Crocs, Eli Lilly, Lockheed Martin, Philip Morris, Rio Tinto, Spotify and More

Major Pharma Stocks Scare Off Short Sellers

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.